See up to 3 months of PFE. The 7-day demo opens the 1M and 3M ranges and puts PFE on your watchlist.
Start 7-day demoLatest PFE insider trades
Albert Bourla - OfficerOpen-market purchase$1.00M- Jennifer B. Damico - OfficerOpen-market sale$83K
About PFIZER INC (PFE)
PFIZER INC is an SEC registrant, filing under CIK 0000078003, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
PFE Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 3 | 114,863 | $2.96M |
| Open-market sale | 1 | 3,278 | $83K |
| Grant or award | 11 | 9,004 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PFE insider transactions (Form 4)
33120 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Johnson Suzanne M. Nora - Director | Grant or award | Phantom Stock Units | 7,687 footnote F2 | $26.67 | $205K | |
| ||||||
 Dan R. Littman - Director | Grant or award | Phantom Stock Units | 7,687 footnote F2 | $26.67 | $205K | |
| ||||||
| Ronald E. Blaylock - Director | Grant or award | Phantom Stock Units | 7,687 footnote F2 | $26.67 | $205K | |
| ||||||
| Mortimer J. Buckley - Director | Grant or award | Phantom Stock Units | 7,687 footnote F2 | $26.67 | $205K | |
| ||||||
 Susan Desmond-Hellmann - Director | Grant or award | Phantom Stock Units | 7,687 footnote F2 | $26.67 | $205K | |
| ||||||
| Joseph Echevarria - Director | Grant or award | Phantom Stock Units | 7,687 footnote F2 | $26.67 | $205K | |
| ||||||
 Shantanu Narayen - Director | Grant or award | Phantom Stock Units | 7,687 footnote F2 | $26.67 | $205K | |
| ||||||
 James Quincey - Director | Grant or award | Phantom Stock Units | 7,687 footnote F2 | $26.67 | $205K | |
| ||||||
 James C. Smith - Director | Grant or award | Phantom Stock Units | 7,687 footnote F2 | $26.67 | $205K | |
| ||||||
 Cyrus Taraporevala - Director | Grant or award | Phantom Stock Units | 7,687 footnote F2 | $26.67 | $205K | |
| ||||||
| Albert Bourla - Officer | Grant or award | Phantom Stock Units SSP | 22 | $27.19 | $598 | |
| Albert Bourla - Officer | Grant or award | Phantom Stock Units SSP | 911 | $27.11 | $25K | |
| Albert Bourla - Officer | Grant or award | Phantom Stock Units SSP | 21 | $28.08 | $590 | |
| Cyrus Taraporevala - Director | Grant or award | Phantom Stock Units | 1,387 | $27.04 | $37K | |
| James C. Smith - Director | Grant or award | Phantom Stock Units | 1,664 | $27.04 | $45K | |
| James Quincey - Director | Grant or award | Phantom Stock Units | 1,433 | $27.04 | $39K | |
| Shantanu Narayen - Director | Grant or award | Phantom Stock Units | 1,849 | $27.04 | $50K | |
| Joseph Echevarria - Director | Grant or award | Phantom Stock Units | 1,710 | $27.04 | $46K | |
| Mortimer J. Buckley - Director | Grant or award | Phantom Stock Units | 1,387 | $27.04 | $37K | |
| Albert Bourla - Officer | Grant or award | Phantom Stock Units SSP | 1,630 | $26.58 | $43K | |
| Jennifer B. Damico - Officer | Grant or award | Common Stock | 5,408 footnote F1 | $0.00 | - | |
| Jennifer B. Damico - Officer | Tax withholding / forfeiture | Common Stock | 826 footnote F2 | $26.62 | $22K | |
| Jennifer B. Damico - Officer | Grant or award | Stock Appreciation Rights | 22,638 | $0.00 | - | |
| Jennifer B. Damico - Officer | Grant or award | Common Stock | 16,311 footnote F1 | $0.00 | - | |
| ||||||
| Albert Bourla - Officer | Grant or award | Stock Appreciation Rights | 708,666 | $0.00 | - | |
| Christoffel Boshoff - Officer | Grant or award | Stock Appreciation Rights | 259,844 | $0.00 | - | |
| David M. Denton - Officer | Grant or award | Stock Appreciation Rights | 216,537 | $0.00 | - | |
 Douglas M. Lankler - Officer | Grant or award | Stock Appreciation Rights | 194,883 | $0.00 | - | |
 Aamir Malik - Officer | Grant or award | Stock Appreciation Rights | 194,883 | $0.00 | - | |
 Andrew Baum - Officer | Grant or award | Stock Appreciation Rights | 303,151 | $0.00 | - | |
| Lidia Fonseca - Officer | Grant or award | Stock Appreciation Rights | 82,284 | $0.00 | - | |
 Michael McDermott - Officer | Grant or award | Stock Appreciation Rights | 151,576 | $0.00 | - | |
 Payal Sahni - Officer | Grant or award | Stock Appreciation Rights | 108,268 | $0.00 | - | |
Item 2.02, 9.01
Item 7.01
Item 5.02, 9.01
Item 2.02, 9.01
Stock trades in PFE disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Carol D. MillerRepublican, WV-01 | Sale |
PFE insider trading FAQ
What is the latest insider trade for PFE?
PFIZER INC (PFE) had 15 insider filings in the last 90 days, with the most recent on 2026-10-01. The full record for PFE runs to 120 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PFE stock?
3 insider purchases of PFE were filed in the last 90 days, totaling $2.96M.
How many insiders are selling PFE stock?
1 insider sale of PFE was filed in the last 90 days, totaling $83K.
Where can I see PFE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PFE Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Albert Bourla view on EDGAR
- - Mortimer J. Buckley view on EDGAR
- - Joseph Echevarria view on EDGAR
- - Shantanu Narayen view on EDGAR
- - James Quincey view on EDGAR
- - James C. Smith view on EDGAR
- - Cyrus Taraporevala view on EDGAR
- - Albert Bourla view on EDGAR
- - Albert Bourla view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where PFE's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PFE with a 7-day demo
- PFE on your watchlist
- Every PFE Form 4 filing on record
- Up to 3 months of PFE price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
